-
241
Standalone Ayurveda management of Hodgkin's lymphoma: A case report
Published 2023-11-01Subjects: “…Hodgkin's lymphoma…”
Get full text
Article -
242
Immune Dysfunction and the Pathogenesis of AIDS-associated non-Hodgkin's Lymphoma
Published 1998-05-01Get full text
Article -
243
Hodgkin's lymphoma with unusual pulmonary presentations: Reporting two cases
Published 2017-01-01Subjects: “…Classical Hodgkin's lymphoma…”
Get full text
Article -
244
Role of brentuximab vedotin in the treatment of relapsed or refractory Hodgkin lymphoma
Published 2014-02-01“…Keywords: Hodgkin lymphoma, brentuximab vedotin, CD 30, antibody-drug conjugate…”
Get full text
Article -
245
Non-Hodgkins lymphoma of the nasal cavity: A case report
Published 2023-11-01“…The mass was subsequently diagnosed as diffuse large B-cell non-Hodgkin lymphoma (NHL). Nasal/paranasal space involvement in NHL is uncommon, representing only 0.2%-2% of cases. …”
Get full text
Article -
246
Molecular Characterisation of Epstein–Barr Virus in Classical Hodgkin Lymphoma
Published 2022-12-01“…Hodgkin lymphomas (HLs) are a heterogeneous group of lymphoid neoplasia associated with Epstein–Barr virus (EBV) infection. …”
Get full text
Article -
247
Before it crumbles: Fulminant Hepatic Failure secondary to Hodgkin's Lymphoma
Published 2014-11-01Subjects: Get full text
Article -
248
The “Hand as Foot” memorizing method in the radiation field of Hodgkin lymphoma
Published 2022-10-01Subjects: “…Hodgkin lymphoma…”
Get full text
Article -
249
-
250
P057 (0108) COGNITIVE IMPAIRMENTS IN PATIENTS WITH HODGKIN'S LYMPHOMA
Published 2018-10-01Get full text
Article -
251
Brentuximab vedotin is the first target drug in the treatment of hodgkin lymphoma
Published 2018-11-01Subjects: “…hodgkin lymphoma…”
Get full text
Article -
252
CLINIC, DIAGNOSIS AND TREATMENT OF NON-HODGKIN'S LYMPHOMA OF THE THYROID GLAND
Published 2022-12-01Get full text
Article -
253
PET-adapted approaches to primary therapy for advanced Hodgkin lymphoma
Published 2020-06-01“…Recent results of randomized phase III studies of FDG-PET-adapted therapy for advanced Hodgkin lymphoma (HL) have clearly demonstrated benefit to alteration of treatment according to interim response, in particular regarding reducing toxicity while maintaining efficacy. …”
Get full text
Article -
254
Outcome of first relapse of Hodgkin lymphoma: Single Institution experience
Published 2020-11-01“… Objectives: 1:To determine outcome of first relapse of Hodgkin Lymphoma with standard dose chemotherapy. 2: To identify the prognostic factors predicting survival outcome in pediatric relapsed Hodgkin lymphoma. …”
Get full text
Article -
255
Hodgkin Reed–Sternberg-Like Cells in Non-Hodgkin Lymphoma
Published 2020-11-01Subjects: Get full text
Article -
256
Modeling Gene-Environment Interaction for the Risk of Non-hodgkin Lymphoma
Published 2019-01-01Subjects: Get full text
Article -
257
Usefulness of BATF3 Immunohistochemistry in Diagnosing Classical Hodgkin Lymphoma
Published 2021-06-01Subjects: “…classical Hodgkin lymphoma 1…”
Get full text
Article -
258
Advances and Clinical Outcomes in Hodgkin Lymphoma in the Era of Novel Therapies
Published 2023-03-01“…Hodgkin lymphoma (HL) is traditionally considered one of the hematological malignancies with the highest rate of cure, ranging from 70 to 90% depending on the disease and patient features [...]…”
Get full text
Article -
259
Diagnosis and Prognosis of Non-Hodgkin's Lymphoma with Bone Marrow Involvement
Published 2018-08-01Subjects: Get full text
Article -
260
Primary testicular non-Hodgkin's lymphoma: a review article
Get full text
Article